IP Library › Granted Patent US 11,968,978
Granted Patent B2
US 11,968,978 · App. 16/940,787 · Granted Apr 30, 2024

Formulations and methods for treating photosynthetic organisms and enhancing qualities and quantities of yields with glycan composite formulations

Inventor: Arthur M. Nonomura (Litchfield Park, AZ)
Assignee: Innovation Hammer LLC
A01N43/16A01N55/02A01N59/00A01N63/10A01N63/50A01N65/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,968,978
App. No.
16/940,787
Granted
Apr 30, 2024
Kind
B2
Abstract

Glycan Composites and methods for rendering glycan composites for the treatment of photosynthetic organisms, including the steps of formulating branched glycan deglycosylates into coordination complex compositions resulting in water-borne availability; stability during storage; applying a suitable volume of the resulting mixture to one or more photosynthetic organisms; delivery to photosynthetic organisms; metabolically based growth of crops; enhanced qualities and increased quantities of crops; and systems and compositions for the same.

Claims (15)

1. A formulation comprising an algal glycan composite to promote crop health and growth of photosynthetic organisms, said algal glycan composite comprising one or more branched glycans with a glycopyranose or acylglycosamine terminal ligand blended with a Ca 2+ coordination complex and one or more D-block transition metal 2+ coordination complexes.

2. The formulation of claim 1 , wherein said one or more branched glycans is selected from the group consisting of O-linked glycans and N-linked glycans with Branched Glycan m-n , where m=1-8 and n=1-8.

3. The formulation of claim 1 , wherein said glycan composite is present in said formulation in the weight amount of 1 ppb to 1% and said one or more D-block transition metal 2+ coordination complexes are present in the weight amount of 0.1 ppb to 1%.

4. The formulation of claim 1 , wherein said one or more D-block transition metal 2+ coordination complexes is a Mn 2+ transition metal 2+ coordination complex, and wherein said one or more branched glycans is selected from branched Glycopyranosyl 1-8 -N-acylglycosamine 1-3 .

5. The formulation of claim 1 , wherein said one or more branched glycans is selected from the group consisting of branched Glycan-N-acylglycosamine; Glycan-N-acylgalactosamine; Glycan-N-acylglucosamine; Glycan-N-acylneuramine; GalactopyranosylGlucopyranosylMannopyranosyl-N-glycan; Mannopyranosyl 1-8 -N-glycan; Mannopyranosyl 1-8 -N-acylglucosamine 1-3 ; Mannopyranosyl 1-8 -N-acylgalactosamine 1-3 ; Galactopyranosyl 1-8 -N-acylglucosamine 1-3 ; and MannopyranosylXylosyl-N-acylgalactosamine 1-3 .

6. The formulation of claim 1 , wherein said algal glycan composite is a plant growth regulator.

7. The formulation of claim 1 , wherein said algal glycan composite is an algal biostimulant.

8. The formulation of claim 1 , wherein said algal glycan composite is an algal elicitor.

9. The formulation of claim 1 , wherein said algal glycan composite comprises one or more partially hydrolyzed algal natural sources selected from the group consisting of algal Chlorophyta, algal Rhodophyta and algal Chromoveolata.

10. The formulation of claim 1 , wherein said one or more branched glycans is an N-linked glycan amino-functionalized mannose having the following formula:

11. The formulation of claim 1 , wherein said one or more branched glycans is an N-linked trigalactosyl-N-acyl galactosamine.

12. The formulation of claim 1 , wherein said one or more branched glycans is an N-linked glycan Mannopyranosyl α1,3(Mannopyranosyl α1,6)Mannopyranosyl β1,4-N-AcetylGalactosamine having the following formula:

13. The formulation of claim 1 , wherein said one or more branched glycans is selected from the group consisting of the O-linked branched glycans xylosyl-Mannopyranose 1-24 .

14. The formulation of claim 1 , further comprising one or more anionic components selected from the group consisting of polydentate alkylamide chelants, aconitates, citrates, fumarates, glutarates, malates, oxaloacetates, succinates, acids, salts and esters thereof.

15. The formulation of claim 1 , wherein said one or more D-Block transition metals 2+ is selected from the group consisting of Mn 2+ , Fe 2+ , Co 2+ , Ni 2+ and Zn 2+ .

Continuity (4)
Division 16666466 · Oct 29, 2019
Division 15492110 · Apr 20, 2017
Provisional Application 62329226 · Apr 29, 2016
Related Publication 20200404913A1 · Dec 31, 2020